Skip to content

Clinical trials

Phase 1 trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Country / region: Switzerland Clear all

497 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20033
20048
20059
200617
200721
200819
200926
201030
201125
201224
201323
201426
201515
201621
201726
201821
201919
202023
202121
202225
202329
202422
202514
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed349
Terminated47
Recruiting34
Unknown status26
Active, not recruiting26
Withdrawn7
Not yet recruiting4
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland75
University of Zurich36
Novartis Pharmaceuticals27
Centre Hospitalier Universitaire Vaudois19
Insel Gruppe AG, University Hospital Bern14
Amgen13
European Organisation for Research and Treatment of Cancer - EORTC13
Aziende Chimiche Riunite Angelini Francesco S.p.A11
Bayer9
Novartis9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms26
Melanoma20
Carcinoma, Non-Small-Cell Lung18
Colorectal Neoplasms15
Glioblastoma13
Ovarian Neoplasms12
Breast Neoplasms11
Lymphoma, Non-Hodgkin9
Neoplasm Metastasis9
Pancreatic Neoplasms9

Trials

Showing 76 to 100 of 497. Each trial links to its page on Pharma Observatory.

397 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.